Triarco Industries Inc. 27305
September 13, 2004
Triarco Industries Inc.
Alphastat® Lowers DHT More Effectively Than Saw Palmetto withHigh Compliance and Cost Efficiency
WAYNE, N.J.Triarco Industrieswill announce the results of a pilot clinical trial with Alphastat®, a dietarysupplement shown to clinically reduce DHT levels. Besides inhibiting 5-alphareductase, decreasing circulating DHT levels and reducing inflammation, newevidence shows Alphastat also inhibits the aromatase enzyme. These uniqueattributes make it useful for mens and womens formulations includinghormonal balance, urinary function, sexual performance and androgenic alopecia.
The VendorWorks presentation will be given Friday, Oct. 1,from 8 to 8:50 a.m. at SupplySide West. For additional information, visitwww.triarco.com.
You May Also Like